Martin Lambert

Summary

Affiliation: University of Hamburg
Country: Germany

Publications

  1. pmc Gender differences in first episode psychotic mania
    Sue M Cotton
    Orygen Youth Health Research Centre, University of Melbourne, Locked Bag 10 35 Poplar Road, Parkville, Victoria, 3052, Australia
    BMC Psychiatry 13:82. 2013
  2. doi request reprint Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia
    M Lambert
    Psychosis Early Detection and Intervention Centre, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Acta Psychiatr Scand 118:220-9. 2008
  3. ncbi request reprint Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study
    M Lambert
    Centre for Psychosocial Medicine, Department for Psychiatry and Psychotherapy, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Acta Psychiatr Scand 111:232-43. 2005
  4. ncbi request reprint The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis
    M Lambert
    Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Psychosis Early Detection and Intervention Centre PEDIC, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Acta Psychiatr Scand 112:141-8. 2005
  5. ncbi request reprint Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study
    M Lambert
    Department of Psychiatry and Psychotherapy, University of Hamburg, Martini Street 52, 20246 Hamburg, Germany
    Pharmacopsychiatry 38:206-13. 2005
  6. doi request reprint Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial)
    Martin Lambert
    Psychosis Centre, Department for Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    J Clin Psychiatry 71:1313-23. 2010
  7. pmc Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later
    Martin Lambert
    Psychosis Centre, Department of Psychiatry and Psychotherapy, Center for Psychosocial Medicine, University Medical Center Hamburg Eppendorf, German
    Dialogues Clin Neurosci 12:393-407. 2010
  8. ncbi request reprint Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia
    Martin Lambert
    Psychosis Early Detection and Intervention Centre PEDIC, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Clin Psychiatry 67:1690-7. 2006
  9. ncbi request reprint Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride
    M Lambert
    Psychosis Early Detection and Intervention Centre PEDIC, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy of the University Hospital Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
    Acta Psychiatr Scand 115:106-13. 2007
  10. doi request reprint Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride
    M Lambert
    Psychosis Early Detection and Intervention Centre PEDIC, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg Eppendorf
    Pharmacopsychiatry 42:277-83. 2009

Detail Information

Publications67

  1. pmc Gender differences in first episode psychotic mania
    Sue M Cotton
    Orygen Youth Health Research Centre, University of Melbourne, Locked Bag 10 35 Poplar Road, Parkville, Victoria, 3052, Australia
    BMC Psychiatry 13:82. 2013
    ..The aim of this paper was to delineate the impact of gender on premorbid history, onset, and 18 month outcomes of first episode psychotic mania (FEPM) patients...
  2. doi request reprint Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia
    M Lambert
    Psychosis Early Detection and Intervention Centre, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Acta Psychiatr Scand 118:220-9. 2008
    ..Few studies have prospectively examined remission and recovery as well as their predictors in schizophrenia simultaneously. Aims of the study were to identify remission and recovery rates as well as their predictors in schizophrenia...
  3. ncbi request reprint Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study
    M Lambert
    Centre for Psychosocial Medicine, Department for Psychiatry and Psychotherapy, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Acta Psychiatr Scand 111:232-43. 2005
    ..The European Schizophrenia Out-patient Health Outcomes study is an observational study investigating treatment in schizophrenia. We report treatment-emergent adverse events during the first 6 months of treatment...
  4. ncbi request reprint The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis
    M Lambert
    Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Psychosis Early Detection and Intervention Centre PEDIC, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Acta Psychiatr Scand 112:141-8. 2005
    ..The main aim of the present study was to assess the impact of baseline SUD and course of SUD on remission of positive symptoms...
  5. ncbi request reprint Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study
    M Lambert
    Department of Psychiatry and Psychotherapy, University of Hamburg, Martini Street 52, 20246 Hamburg, Germany
    Pharmacopsychiatry 38:206-13. 2005
    ..Previous studies comparing olanzapine (OLZ) and risperidone (RIS) have tended to focus on multiple-episode patients, with no studies examining their comparative efficacy in a non-selective sample of first-episode psychosis...
  6. doi request reprint Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial)
    Martin Lambert
    Psychosis Centre, Department for Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    J Clin Psychiatry 71:1313-23. 2010
    ....
  7. pmc Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later
    Martin Lambert
    Psychosis Centre, Department of Psychiatry and Psychotherapy, Center for Psychosocial Medicine, University Medical Center Hamburg Eppendorf, German
    Dialogues Clin Neurosci 12:393-407. 2010
    ..Future research should therefore search for criteria of these dimensions and test whether the RSWG remission criteria consistently predict a "good" outcome with respect to functioning and quality of life...
  8. ncbi request reprint Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia
    Martin Lambert
    Psychosis Early Detection and Intervention Centre PEDIC, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Clin Psychiatry 67:1690-7. 2006
    ....
  9. ncbi request reprint Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride
    M Lambert
    Psychosis Early Detection and Intervention Centre PEDIC, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy of the University Hospital Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
    Acta Psychiatr Scand 115:106-13. 2007
    ..Studies of subjective wellbeing (SW) in schizophrenia have missed to define and to assess rate and predictors of SW response (SW-res) and SW remission (SW-rem)...
  10. doi request reprint Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride
    M Lambert
    Psychosis Early Detection and Intervention Centre PEDIC, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg Eppendorf
    Pharmacopsychiatry 42:277-83. 2009
    ..Limiting factors of these studies include the restriction on symptomatic outcome, the inclusion of mostly moderately ill patients, and the use of various antipsychotics...
  11. doi request reprint Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years
    Martin Lambert
    Psychosis Centre, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Germany
    Schizophr Res 107:165-72. 2009
    ....
  12. doi request reprint Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder
    M Lambert
    Psychosis Early Detection and Intervention Centre PEDIC, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Centre, Hamburg Eppendorf, Germany
    Pharmacopsychiatry 41:182-9. 2008
    ..Agitation is a common phenomenon in schizophrenia or acute mania. Because of the inability of patients to give informed consent in such situations, data from consenting studies are limited...
  13. ncbi request reprint Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence
    M Lambert
    Centre for Psychosocial Medicine, Department for Psychiatry and Psychotherapy, University of Hamburg, Martini Street 52, 20246 Hamburg, Germany
    Eur Psychiatry 19:415-22. 2004
    ....
  14. ncbi request reprint Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life
    Martin Lambert
    Centre for Psychosocial Medicine, Department for Psychiatry and Psychotherapy, University of Hamburg, Hamburg, Germany
    CNS Drugs 18:5-17; discussion 41-3. 2004
    ..Ideally, an atypical drug which is known not to have a negative effect on attention, affect or motivation should be chosen...
  15. ncbi request reprint Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance
    M Lambert
    Centre for Psychosocial Medicine, Department for Psychiatry and Psychotherapy, University of Hamburg, Hamburg, Germany
    Pharmacopsychiatry 36:S181-90. 2003
    ..This article reviews existing literature in order to approach relevant questions for pharmacotherapy...
  16. ncbi request reprint [Conversion from typical to atypical neuroleptics. Guidelines for ambulatory and inpatient treatment]
    M Lambert
    Klinik für Psychiatrie und Psychotherapie der Universität Hamburg
    Nervenarzt 71:859-75. 2000
    ..The present article addresses guidelines for the conversion from conventional to atypical neuroleptics in inpatient and outpatient settings...
  17. ncbi request reprint Management of incomplete remission and treatment resistance in first-episode psychosis
    Martin Lambert
    University Medical Centre Hamburg Eppendorf, Psychosis Early Detection and Intervention Centre, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistreet 52, D 20246 Hamburg, Germany
    Expert Opin Pharmacother 9:2039-51. 2008
    ..Incomplete remission and treatment resistance are common even in first-episode psychosis patients...
  18. ncbi request reprint Pharmacotherapy of first-episode psychosis
    Martin Lambert
    Centre for Psychosocial Medicine, Clinic for Psychiatry and Psychotherapy of the University of Hamburg, Martinistreet 52, 20246 Hamburg, Germany
    Expert Opin Pharmacother 4:717-50. 2003
    ....
  19. ncbi request reprint Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders
    Martin Lambert
    Department for Psychiatry and Psychotherapy, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany
    Int Clin Psychopharmacol 18:251-60. 2003
    ..The results underline the need of Phase IV studies for the assessment of clinical antipsychotic efficacy and tolerability...
  20. doi request reprint Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients
    Christian G Huber
    Psychosis Early Detection and Intervention Centre, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Centre Hamburg Eppendorf, Germany
    Schizophr Res 100:342-8. 2008
    ..Clinical management of aggression depends on the availability of easily administrable measurements allowing reliable evaluation. The present study's aim is to validate a Clinical Global Impression-Severity of Aggression scale (CGI-A)...
  21. doi request reprint Subjective wellbeing under quetiapine treatment: effect of diagnosis, mood state, and anxiety
    Martin Lambert
    Psychosis Early Detection and Intervention Centre PEDIC, Centre for Psychosocial Medicine, Department of Psychiatry, University Medical Center Hamburg Eppendorf, Germany
    Schizophr Res 110:72-9. 2009
    ..To examine the effect of diagnosis, mood state, and anxiety on subjective wellbeing in patients with affective and non-affective psychotic disorders treated with quetiapine IR...
  22. ncbi request reprint Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia
    Anne Karow
    Center for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Clin Psychiatry 68:75-80. 2007
    ....
  23. doi request reprint Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models
    Martin Lambert
    Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Centre Hamburg Eppendorf, Germany
    J Clin Psychopharmacol 31:226-30. 2011
    ..This study examined the differential effects of first- (FGAs) versus second-generation antipsychotics (SGAs) on subjective well-being in patients with schizophrenia...
  24. doi request reprint Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial)
    Anne Karow
    Department of Psychiatry and Psychotherapy, Psychosis Centre, Centre for Psychosocial Medicine, University Medical Center Hamburg Eppendorf, Germany
    J Clin Psychiatry 73:e402-8. 2012
    ..ACT was specifically developed for patients with schizophrenia, delivered by psychosis experts highly trained in respective psychotherapies, and embedded into an integrated care system...
  25. doi request reprint Brief Psychiatric Rating Scale - Excited Component (BPRS-EC) and neuropsychological dysfunction predict aggression, suicidality, and involuntary treatment in first-episode psychosis
    Christian G Huber
    Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Centre Hamburg Eppendorf, Martinistr 52, D 20246 Hamburg, Germany
    Schizophr Res 134:273-8. 2012
    ..Although there are studies on prevalence and clinical predictors of these conditions, little is known on the influence of psychopathology and neuropsychological dysfunction...
  26. ncbi request reprint Diagnostic stability 18 months after treatment initiation for first-episode psychosis
    Benno G Schimmelmann
    Centre for Psychosocial Medicine, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University Hospital Hamburg Eppendorf, Hamburg, Germany
    J Clin Psychiatry 66:1239-46. 2005
    ..2) Comparison between those patients who shifted from DSM-IV schizophreniform disorder to schizophrenia or schizo-affective disorder and those whose diagnosis of schizophreniform disorder remained stable...
  27. doi request reprint Differentiating schizoaffective and bipolar I disorder in first-episode psychotic mania
    Daniel Schottle
    Psychosis Early Detection and Intervention Centre PEDIC, Centre for Psychosocial Medicine, Department for Psychiatry and Psychotherapy, University Medical Centre Hamburg Eppendorf, Germany
    Schizophr Res 140:31-6. 2012
    ..This study aims to differentiate schizoaffective disorder (SAD) and bipolar-I-disorder (BD) in first-episode psychotic mania (FEPM)...
  28. ncbi request reprint Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial
    Duerten Kudla
    Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    Eur Psychiatry 22:195-202. 2007
    ..Secondary objectives included quality of life, subjective well-being, tolerability, and safety...
  29. doi request reprint Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis
    Martin Lambert
    Psychosis Early Detection and Intervention Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Clin Psychopharmacol 30:565-72. 2010
    ..The present study aims to assess the prevalence and predictors of such a "medication refusal" subgroup and its association with illness outcome...
  30. pmc The impact of subjective well-being under neuroleptic treatment on compliance and remission
    Walter de Millas
    Centre for Psychosocial Medicine, Department for Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Dialogues Clin Neurosci 8:131-6. 2006
    ..The data strongly suggest that a systematic evaluation of the patient's perspective of antipsychotic treatment is meaningful and necessary to increase compliance, functional outcome, and long-term prognosis...
  31. ncbi request reprint Incomplete remission and treatment resistance in first-episode psychosis: definition, prevalence and predictors
    Christian G Huber
    University Medical Centre Hamburg Eppendorf, Psychosis Early Detection and Intervention Centre, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistreet 52, D 20246 Hamburg, Germany
    Expert Opin Pharmacother 9:2027-38. 2008
    ..Different definitions for these terms have been used in psychiatric research, making generalized statements about the prevalence and predictors of treatment resistance difficult...
  32. doi request reprint Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment
    M Lambert
    Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg Eppendorf Hamburg, Martinistreet 52, 20246 Hamburg, Germany
    Eur Psychiatry 25:220-9. 2010
    ..To measure symptomatic and functional remission in patients treated with risperidone long-acting injectable (RLAI)...
  33. doi request reprint Estimated prevalence of mental disorders and the desire for social distance--results from population surveys in two large German cities
    Olaf von dem Knesebeck
    Department of Medical Sociology and Health Economics, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany Electronic address
    Psychiatry Res 209:670-4. 2013
    ..Our results indicate that this may not generally be an effective way to reduce stigma. ..
  34. doi request reprint The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians
    Dieter Naber
    Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    CNS Drugs 23:649-59. 2009
    ..There is no single antipsychotic that is best for every schizophrenia patient, as individual responses differ markedly. For successfully individualized treatment, a multitude of antipsychotic options are needed...
  35. ncbi request reprint Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain
    Christian Haasen
    Department of Psychiary and Psychotherapy, University Hospital Eppendorf, Hamburg, Germany
    Int Clin Psychopharmacol 18:113-5. 2003
    ....
  36. ncbi request reprint Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine
    Stefan Bender
    Department of Psychiatry and Psychotherapy, University of Duisburg Essen, Germany
    Int J Neuropsychopharmacol 9:135-45. 2006
    ..However, Stroop reaction time improved with olanzapine while clozapine had a stronger effect on improving negative symptoms, thus suggestive of a differential drug effect...
  37. ncbi request reprint Subjective cognitive dysfunction in first-episode and chronic schizophrenic patients
    S Moritz
    Clinic for Psychiatry and Psychotherapy, University Clinic Hamburg-Eppendorf, Hamburg, Germany
    Compr Psychiatry 42:213-6. 2001
    ..In marked contrast to a Kraepelinian view of schizophrenia, the present data confirm previous studies conducted with objective neuropsychological tests that schizophrenia is a neurodevelopmental rather than a neurodegenerative disorder...
  38. doi request reprint Integrated care in patients with schizophrenia: results of trials published between 2011 and 2013 focusing on effectiveness and efficiency
    Daniel Schottle
    Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany
    Curr Opin Psychiatry 26:384-408. 2013
    ..Overview on integrated care trials focusing on effectiveness and efficiency published from 2011 to 2013...
  39. doi request reprint Drug safety and efficacy evaluation of sertindole for schizophrenia
    Evangelos Karamatskos
    University Medical Center Hamburg Eppendorf, Centre of Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistr 52, D 20246 Hamburg, Germany
    Expert Opin Drug Saf 11:1047-62. 2012
    ....
  40. pmc Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosi
    Andreas Bechdolf
    Department of Psychiatry and Psychotherapy, University of Cologne, Kerpener Str 62, 50924 Cologne, Germany
    Schizophr Bull 37:S111-21. 2011
    ..When the final results of the trial are available, PREVENT will substantially expand the current limited evidence base for best clinical practice in people at-risk (prodromal) of first-episode psychosis...
  41. ncbi request reprint Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism
    Dieter Naber
    Department of Psychiatry and Psychotherapy, Universitatsklinikum Hamburg Eppendorf, Martinistrasse 52, Hamburg 20246, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 28:1213-9. 2004
    ..However, only post-marketing experience will show whether the positive results of these controlled trials can be replicated in everyday practice...
  42. ncbi request reprint Under what circumstances do patients with schizophrenia jump to conclusions? A liberal acceptance account
    Steffen Moritz
    Universitatsklinikum Hamburg Eppendorf, Klinik fur Psychiatrie und Psychotherapie, Germany
    Br J Clin Psychol 46:127-37. 2007
    ..We have recently proposed a liberal acceptance (LA) bias to account for decision-making biases in schizophrenia, which claims that under heightened ambiguity the jump to conclusions (JTC) bias is abolished in schizophrenia...
  43. doi request reprint [Sexual problems in patients with schizophrenia]
    Daniel Schottle
    Psychosen Ersterkennungs und Behandlungsprojekt PEB, Zentrum fur Psychosoziale Medizin, Klinik fur Psychiatrie und Psychotherapie, Universitatsklinikum Hamburg Eppendorf
    Psychiatr Prax 36:160-8. 2009
    ..Overview on the current knowledge concerning sexual dysfunctions in patients with schizophrenia and implications for treatment, compliance, quality of life and partnership...
  44. ncbi request reprint [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease]
    Dieter Naber
    Universitatsklinikum Hamburg Eppendorf, Klinik fur Psychiatrie und Psychotherapie
    Psychiatr Prax 31:S230-2. 2004
    ....
  45. ncbi request reprint PANSS syndromes and quality of life in schizophrenia
    A Karow
    Department of Psychiatry and Psychotherapy, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Psychopathology 38:320-6. 2005
    ..The leading hypotheses were: (1) affective symptoms, especially depression and anxiety, are mostly associated with QOL longitudinally and (2) in the acute phase, QOL is also associated with positive schizophrenia symptoms...
  46. ncbi request reprint Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia
    D Naber
    Department of Psychiatry and Psychotherapy, University Hospital Hamburg Eppendorf, Germany
    Acta Psychiatr Scand 111:106-15. 2005
    ..This randomized double-blind multicenter trial evaluated the effects of olanzapine vs. clozapine on subjective well-being, quality of life (QOL) and clinical outcome...
  47. ncbi request reprint Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics
    S Moritz
    Universitäts Krankenhaus Hamburg Eppendorf, Klinik fur Psychiatrie und Psychotherapie, Hamburg, Deutschland
    Psychopathology 33:48-51. 2000
    ..005). It is suggested that the exploration and treatment of neuropsychological deficits in schizophrenia is of great clinical importance with regard to its impact on both functional and symptomatic outcome in schizophrenia...
  48. ncbi request reprint [Atypical antipsychotics in therapy refractory schizophrenia]
    I Schafer
    Klinik für Psychiatrie und Psychoterapie der Universitätsklinik Hamburg Eppendorf
    Nervenarzt 75:79-91. 2004
    ..Case studies also indicate the efficacy of combining different atypical antipsychotics, but no systematic research on this issue has been done so far...
  49. ncbi request reprint [The initial dysphoric reaction (IDR) to the first dose of neuroleptics]
    B Graf Schimmelmann
    Klinik fur Kinder und Jugendpsychiatrie und psychotherapie, Universitatsklinikum Hamburg Eppendorf, Hamburg
    Nervenarzt 75:36-43. 2004
    ..Further research should include placebo-controlled studies and the evaluation of specific pretreatment variables. To assess the aetiology of IDR, further basic research is needed...
  50. ncbi request reprint Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics
    S Moritz
    Universitäts Krankenhaus Hamburg Eppendorf, Klinik fur Psychiatrie und Psychotherapie, Martinistrasse 52, D 20246, Hamburg, Germany
    Eur Psychiatry 16:354-61. 2001
    ..Previous findings reporting correlations between negative symptomatology and neurocognition may have been confounded by the adverse consequences of typical neuroleptics...
  51. ncbi request reprint Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs
    D Naber
    Universitäts Krankenhaus Hamburg Eppendorf, Clinic for Psychiatry and Psychotherapy, Martinistrasse 52, 20246 Hamburg, Germany
    Schizophr Res 50:79-88. 2001
    ..It is concluded that the assessment of subjective well-being under antipsychotic treatment provides an independent outcome measure which is relevant to compliance...
  52. doi request reprint Socioeconomic status and beliefs about depression, schizophrenia and eating disorders
    Olaf von dem Knesebeck
    Department of Medical Sociology and Health Economics, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    Soc Psychiatry Psychiatr Epidemiol 48:775-82. 2013
    ..The association between socioeconomic status (SES) and knowledge/belief about depression, schizophrenia and eating disorders will be analysed...
  53. doi request reprint Rationale and content of psychenet: the Hamburg Network for Mental Health
    Martin Härter
    Department of Medical Psychology, University Medical Centre Hamburg Eppendorf, Martinistrase 52, W 26, 20246 Hamburg, Germany
    Eur Arch Psychiatry Clin Neurosci 262:S57-63. 2012
    ..Those networks are accompanied by additional measures, for example, for improving information and education, addressing occupational health or strengthening the participation of patients and their families suffering from mental illness...
  54. doi request reprint Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER)
    Dieter Naber
    Department of Psychiatry and Psychotherapy, Center of Psychosocial Medicine, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany Electronic address
    Eur Neuropsychopharmacol 23:1257-69. 2013
    ..A secondary objective (SWN-K total score) established non-inferiority of quetiapine XR to risperidone at Month 12...
  55. ncbi request reprint Manifestation of multiple sclerosis with paranoid-hallucinatory psychosis
    Jens Reimer
    J Neurol 253:531-2. 2006
  56. doi request reprint A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders
    Benno Graf Schimmelmann
    Department of Child and Adolescent Psychiatry, University of Duisburg Essen, Virchowstrasse 174, 45147 Essen, Germany
    J Child Adolesc Psychopharmacol 17:768-78. 2007
    ..The aim of this study was to investigate the effectiveness, tolerability, and safety of quetiapine in adolescents with schizophrenia, schizophreniform, and schizoaffective disorders in a prospective open-label study...
  57. doi request reprint Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort
    Benno G Schimmelmann
    Department of Child and Adolescent Psychiatry and Psychotherapy, University of Duisburg Essen, Virchowstrasse 174, 45147 Essen, Germany
    J Psychiatr Res 42:982-90. 2008
    ..To assess the impact of duration of untreated psychosis (DUP) on baseline and 18-month follow-up characteristics controlling for relevant confounders in an epidemiological first-episode psychosis (FEP) cohort...
  58. ncbi request reprint Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia
    Peter M Wehmeier
    Medical Department, Child and Adolescent Psychiatry, Lilly Deutschland, Saalburgstr 153, 61350 Bad Homburg, Germany
    J Psychiatr Res 42:676-83. 2008
    ..These findings suggest that various factors may predict whether a patient with schizophrenia experiences a continuously high QoL, a continuously moderate QoL, a continuously low QoL, or improving QoL whilst on antipsychotic treatment...
  59. ncbi request reprint Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients
    Benno G Schimmelmann
    Department of Child and Adolescent Psychiatry and Psychotherapy, University of Duisburg Essen, Virchowstr 174, 45147 Essen, Germany
    Schizophr Res 95:1-8. 2007
    ..To assess pre-treatment, baseline, and outcome differences of patients with early- (onset<age 18) and adult-onset (onset>or=age 18) psychosis in an epidemiological cohort of first-episode patients...
  60. ncbi request reprint Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study
    Stephen J Wood
    Melbourne Neuropsychiatry Centre, University of Melbourne, c o National Neuroscience Facility, 161 Barry Street, Carlton, Melbourne, Victoria 3053, Australia
    Arch Gen Psychiatry 63:969-76. 2006
    ..These studies have generally been negative, perhaps because gray and white matter volumes inaccurately assess the underlying dysfunction that might be predictive of outcome...
  61. ncbi request reprint Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis
    Philippe Conus
    ORYGEN Research Centre, Parkville, Victoria, Australia
    J Affect Disord 81:259-68. 2004
    ..While some authors have found a correlation between such symptoms and outcome, their predictive value was rather limited in these studies...
  62. ncbi request reprint Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study
    Diego Novick
    Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK
    Psychopharmacology (Berl) 191:1015-22. 2007
    ..Symptomatic remission is an achievable goal of treatment in patients with schizophrenia...
  63. ncbi request reprint Predictors of service disengagement in first-admitted adolescents with psychosis
    Benno Graf Schimmelmann
    Department of Child and Adolescent Psychiatry and Psychotherapy, University of Duisburg Essen, Germany
    J Am Acad Child Adolesc Psychiatry 45:990-9. 2006
    ..To assess the risk and predictors of service disengagement in adolescents with first-episode psychosis (FEP) receiving their first treatment in a long-standing early intervention and prevention centre...
  64. ncbi request reprint Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics
    Benno Graf Schimmelmann
    Department of Child and Adolescent Psychiatry and Psychotherapy, University of Duisburg Essen, Essen, Germany
    J Child Adolesc Psychopharmacol 15:249-58. 2005
    ..The aim of this pilot study was to evaluate the subjective distress-related to different SE and its association with subjective well-being in a sample of adolescents treated with atypical antipsychotics...
  65. ncbi request reprint Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample
    Philippe Conus
    Département Universitaire de Psychiatrie CHUV, Universite de Lausanne, Prilly, Switzerland
    Bipolar Disord 8:221-31. 2006
    ..Such studies have been conducted in selected samples with restrictive measures of outcome. We aimed to explore outcome and its predictors in a catchment area sample of first-episode psychotic mania of DSM-III-R bipolar I disorder...
  66. ncbi request reprint Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges
    W Wolfgang Fleischhacker
    Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    J Clin Psychiatry 69:514-9. 2008
    ....
  67. doi request reprint Familial psychopathology in the First Episode Psychosis Outcome Study
    Katherine I Morley
    ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Victoria, Australia
    Aust N Z J Psychiatry 42:617-26. 2008
    ....